Titan Medical Inc
TSX:TMD
Net Margin
Titan Medical Inc
Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.
Net Margin Across Competitors
| Country | Company | Market Cap |
Net Margin |
||
|---|---|---|---|---|---|
| CA |
|
Titan Medical Inc
TSX:TMD
|
686.5m CAD |
-531%
|
|
| US |
|
Abbott Laboratories
NYSE:ABT
|
230.3B USD |
32%
|
|
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
182.6B USD |
28%
|
|
| US |
|
Boston Scientific Corp
NYSE:BSX
|
149.8B USD |
12%
|
|
| US |
|
Stryker Corp
NYSE:SYK
|
143.5B USD |
12%
|
|
| IE |
|
Medtronic PLC
NYSE:MDT
|
110.7B USD |
14%
|
|
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
51.8B EUR |
9%
|
|
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
48.3B USD |
7%
|
|
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
43.5B USD |
75%
|
|
| US |
|
IDEXX Laboratories Inc
NASDAQ:IDXX
|
42.3B USD |
23%
|
|
| CN |
|
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
|
275.5B CNY |
31%
|
Titan Medical Inc
Glance View
Titan Medical, Inc. engages in the research and development of a computer-assisted robotic surgical technology for application in minimally invasive surgery (MIS). The company is headquartered in Toronto, Ontario and currently employs 49 full-time employees. The company went IPO on 2008-04-28. The firm is developing its Enos system to become the new standard of care in robotic single access surgery, with dual three-dimensional (3D) and two-dimensional (2D) high-definition vision systems, multi-articulating instruments and an ergonomic surgeon workstation. Its multi-articulated instruments bring fluid to position the effectors for grasping, suturing, cutting and coagulation. The Enos surgeon workstation includes a 3D high-definition display to provide a balance of surgical immersion and situational awareness in the operating room.
See Also
Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.
Based on Titan Medical Inc's most recent financial statements, the company has Net Margin of -531.3%.
You don't have any saved screeners yet